These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6627370)

  • 1. [Current status and prospect of brucellosis research in China].
    Cui YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Jun; 4(3):190-1. PubMed ID: 6627370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the study of prevention and control of Brucellosis in China in last 50 years].
    Shang D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):55-7. PubMed ID: 15460005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunobiology of brucellosis].
    Parnas J
    Arzneimittelforschung; 1973 Jan; 23(1):103. PubMed ID: 4125094
    [No Abstract]   [Full Text] [Related]  

  • 4. Brucella abortus strain RB51 vaccine: its advantages and risks.
    Kahler SC
    J Am Vet Med Assoc; 1998 Jul; 213(1):12, 22. PubMed ID: 9656011
    [No Abstract]   [Full Text] [Related]  

  • 5. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
    Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
    Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization against brucellosis in the newborn offspring of healthy and nonimmunized mothers].
    Pilet C; Mallick BB; Le Garrec Y
    Bull Acad Vet Fr; 1967 Jun; 40(6):287-90. PubMed ID: 5611472
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On brucellosis].
    Migliarese Malesani S
    Fracastoro; 1969; 62(6):667-71. PubMed ID: 5384277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Human vaccination against brucellosis (Charles Nicolle)].
    Roux J
    Bull Acad Natl Med; 1986 Feb; 170(2):289-92. PubMed ID: 3527369
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of prevention of human brucellosis in the USSR].
    Verchilova PA
    Bull Off Int Epizoot; 1965; 63(7):1265-77. PubMed ID: 5864694
    [No Abstract]   [Full Text] [Related]  

  • 14. Brucellosis.
    Winton FW
    Br J Hosp Med; 1978 Apr; 19(4):414. PubMed ID: 656678
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of serological response of young and adult sheep to conjunctival vaccination with Rev-1 vaccine by fluorescence polarization assay (FPA) and other serological tests for B. melitensis.
    Stournara A; Minas A; Bourtzi-Chatzopoulou E; Stack J; Koptopoulos G; Petridou E; Sarris K
    Vet Microbiol; 2007 Jan; 119(1):53-64. PubMed ID: 16973307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of vaccine treatment of zoonotic infections].
    Lebedinskiĭ VA; Garin NS
    Voen Med Zh; 1980 Sep; (9):47-50. PubMed ID: 6776687
    [No Abstract]   [Full Text] [Related]  

  • 17. Panel set to create brucellosis vaccine for Yellowstone wildlife.
    Nolen S
    J Am Vet Med Assoc; 1999 Jul; 215(2):153, 157. PubMed ID: 10416464
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of natural resistance to live brucella vaccine in irradiated animals.
    Shevtsova ZV
    Fed Proc Transl Suppl; 1965; 24(3):470-2. PubMed ID: 5212947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Brucellosis among occupationally exposed people: evaluation of immunological tests after vaccination].
    Laudat P; Limet J; Barrat F; Poncelet S; Marquet N; Person JM; Audurier A; Gillant JC; Lienard M; Strady A
    Pathol Biol (Paris); 1993 May; 41(5):457-62. PubMed ID: 8414678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brucellosis vaccine and thyroidin in the treatment of brucellosis in patients with decreased allergic reactivity].
    Lopatina ZhM
    Klin Med (Mosk); 1972 Sep; 50(9):94-6. PubMed ID: 4652982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.